BHST Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -10.75%, SMA50 -15.58%, SMA200 -39.99%). The stock’s 14-day RSI is 33.96 (weak momentum), while the ATR of 0.36 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -65.62% below its high and over -5.38% above its low. Average 10-day trading volume of 30.41 thousand shares is below the 3-month average of 46.28 thousand, indicating normal recent market interest.

BioHarvest Sciences Inc. Common Stock generated EPS of -$0.69 over the past year. Five-year average earnings growth is 45.0%. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $14.00 to $14.00. The high target offers 214.61% upside. The low target suggests 214.61% downside. The mean target is $14.00. This offers 214.61% upside. BioHarvest Sciences Inc. Common Stock earnings surprise history is a mixed track record. The quarter that ended November 13, 2025, missed forecasts by 0.0%. The prior quarter beat by 36.36%. Over the last six quarters, Apple has recorded several small beats. These include -57.98% in October 23, 2024.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

BioHarvest Sciences Inc. Common Stock (NASDAQ:BHST) closed at $4.45 USD, gaining $0.04 (1.02%) from the previous close of $4.40. The stock is currently within 5% of its 52-week low $4.27 and $12.80. With a market capitalization of about $77.36 million, BioHarvest Sciences Inc. Common Stock is classified as a micro-cap and shows higher-than-market volatility (beta ~1.33). Key stats such as the average daily volume over the past year has been around 49.83 thousand shares, volume is running light vs its 52-week average. Headquartered in Vancouver, BC, BioHarvest Sciences Inc. Common Stock operates in the Basic Materials sector and the Agricultural Inputs industry. Led by CEO Ilan Sobel, the company employs approximately 87 people and listed since January 08, 2021. BioHarvest Sciences Inc. operates as a biotechnology company.

BioHarvest Sciences Inc. Common Stock trades at a P/E ratio of -6.55, slightly below the S&P 500 average, with a price-to-sales ratio of 2.38 and a price-to-book ratio of 10.06 reflecting a rich premium to book value. The P/FCF stands at -7.72, also below market averages. Compared to sector medians, BioHarvest Sciences Inc. Common Stock P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Our AI price prediction model suggests that BioHarvest Sciences Inc. Common Stock stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.72%, with price expected at $4.24 by March 04, 2026, within a range of $3.99 to $4.48 3-Month Outlook: Projected fall of -83.82%, reaching $0.72 by May 18, 2026, with a range of $0.47 to $0.89. 1-Year Outlook: Projected loss of -98.88%, with price at $0.05 by February 18, 2027, within a range of $0.00 to $0.10.

BioHarvest Sciences Inc. Common Stock (NASDAQ:BHST) shares are flat -7.32% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows BioHarvest Sciences Inc. Common Stock trading at a premium to the broader market with a P/E of -6.55. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $13.50, suggesting 203.37% upside. Our AI forecast model points to short-term weakness (-4.72% over two weeks), a medium-term fall (-83.82% over three months), and a longer-term loss (-98.88% over one year), with expected trading ranges indicating moderate volatility.